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1. Introduction 
Nuclear loss of oestrogen receptor following its 
nuclear translation is required for some hormonal 
responses [l-3]. In a mouse uterus cell-free system 
nuclei inactivate oestrogen-free and oestrogen-bound 
receptor of cytosol as well as the nuclear receptor [4]. 
This nuclear inactivating activity could have a role in 
the in vivo nuclear turnover of oestrogen receptor and 
in mechanism of oestrogen action [4]. These experi- 
ments show that the receptor inactivating activity is 
present in nuclei and nuclear extracts of oestrogen 
target tissues but not in nuclei and nuclear extracts of 
non-target tissues. Furthermore they suggest hat a 
dephosphorylation process is involved in the inactiva- 
tion of receptor by nuclei. 
2. Materials and methods 
Female Swiss mice (-30 g) were used. The follow- 
ing buffers were used: 10 mM Tris-HCl (pH 7.4) 
containing 1 mM dithiothreitol without (TD buffer) 
or with 1 mM EDTA (TED buffer). Tissues were 
homogenized as in [S] in buffer with 0.25 M added 
sucrose (TD- or TED-sucrose buffers). Purified 
nuclei were prepared layering a suspension of 750 X g 
pellet in TED-sucrose buffer on top of TED buffer 
containing 2.2 M sucrose and centrifuging the sample 
at 150 000 X g for 75 min at 2’C. Nuclear extracts 
were prepared from nuclei suspended in TED buffer, 
shaken at 0°C for 30 min, then sonicated as in [4]. The 
sonicated sample was centrifuged at 150 000 X g for 
10 min at 2°C and the supernatant (called nuclear 
extract) utilized. [‘HI Oestradiol-cytosol receptor 
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complex was obtained by incubating uterus cytosol 
with [3H]oestradiol-17/3 (12 X 10e9 M, spec. act. 
101 Ci/mmol) alone (high specific activity [3H] - 
oestradiol) and in presence of a lOOO-fold excess of 
cold oestradiol (low specific activity [3H]oestradiol) 
at 0°C for 2 h. Specific oestradiol binding activity 
was determined as the difference between cytosol 
binding at 0°C for 2 h of high and low specific activity 
[3H]oestradiol-17/3. Bound oestradiol was separated 
from free-hormone by treatment with dextran-coated 
charcoal. The receptor inactivating experiments were 
performed incubating at 25’C for the indicated times 
[3H]oestradiol-cytosol receptor complex (1 X lo-” 
mol oestrogen binding sites/ml incubation mixture) in 
absence (control) and in presence of either 750 X g 
pellet or nuclei or nuclear extracts. Samples were 
then immediately cooled at O”C, centrifuged at low 
speed to sediment 750 X g pellet or nuclei and the 
supernatants treated with dextran-coated charcoal to 
measure the oestrogen binding activity. Centrifuga- 
tion at low speed was omitted in the case of control 
and samples incubated with nuclear extracts. Proteins 
and DNA were assayed as in [6]. 
3. Results and discussion 
Table 1 shows the loss of [3H]oestradiol-receptor 
complex after incubation at 25’C in presence of nu- 
clei and nuclear extracts from different tissues. As 
expected from [4] the [3H]oestradiol-receptor 
complex is partially inactivated by addition of uter- 
us nuclei. Also nuclei from mammary gland, as well 
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TabLe 1 
Inactivation of [ 3H]oestradiol-l 7@cytosol receptor complex by nuclei and nuclear 
extracts from different tissues 
DNA DNA in incubation Less of complex 
Rotein mixture dug/ml) in cytosol (%I 
Uterus nuclei 0.39 6.7 30 
Mammary gland nuclei 0.26 6.1 24 
Liver nuclei 0.23 5.0 2 
Quadriceps muscle nuclei 0.23 7.9 0 
Uterusnuclear extract - - 30 
Liver nuclear extract - - 0 
Uterine cytosols were frrst labelled with high or low specific activity [‘Hloestradiol-17p 
for 2 h at O*C and then incubated in TED-sucrose buffer (pH 7.4) at 25°C for 20 mm in 
absence (control) and in presence of either nuclei or nuclear extracts trom different 
sources. The extracts were prepared from amounts of nuclei equal to those added as intact 
rmclei to cytosol. After incubation, cytosols incubated with nuclei were centrifuged at 
3200 x g to remove nuclei. Thereafter, cytosols were treated with cluucoai and the specific 
oestrogen-binding activity assessed. A 6% inactivation of control was found and subtracted 
from the inactivation f cytosol added with nuclei or nuclear extracts. Values in table 
are averages from 3 different experiments 
as nuclear extract from uterus, inactivate receptor; on 
the contrary, nuclei from liver and quadriceps muscle 
and nuclear extract from liver are totally ineffective. 
These results how that the receptor inactivating activ- 
ity is specific to oestrogen target issues and support 
the hypothesis that this activity has a physiolo~cal 
role. Another promising result is that the receptor- 
inactivating activity can be quantitatively extracted 
from nuclei, making possible pu~~cation and charac- 
terization of molecule(s) responsible for this activity. 
The possibility that the inactivation of oestrogen 
receptor involves a proteolytic process was then inves- 
tigated. The effect of several protease inhibitors on 
[‘Hloestradiol-170 bound cytosol receptor incubated 
F&l. Effect of phosphatase inhibitors on time-dependent 
inactivation of [‘H] oestradiol-receptor complex by nuclei. 
Cytosol in buffer with sucrose added, was pre-labelled at 
0°C for 2 h at 0°C with high and low specific activity [ 3H]- 
oestradiol-17p, then incubated at 25°C for the indicated 
times in presence of: (A) an equivalent amount of 750 X g 
pellet; (B) nuclei purified from the same amount of 750 X g 
pellet used in A; or (C) nuclear extract prepared from the 
same amount of nuclei used in B. The samples were incubated 
either (*) without inhibitors or (0) with 20 mM NaF, or (A) 
5 mM Na,MoO, or (s@ 0.5 mM Z&l,. In the experiment in 
presence of ZnCi,, EDTA was omitted from buffers. 
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at 25°C for 20 min in presence of an equivalent amount 
of 750 X g pellet from mice uterus was studied. 
0.88 mM pheny~ethyl sulphonyi fluoride, 0.1 mM 
L-I-tosyl-amide-2-phenyl~thylchloromethyl chetone, 
1 mM N-o-p-tosyl-L-lysine chloromethyl chetone HCl 
and 5 pg/ml egg-white trypsin inhibitor do not inhibit 
the inactivation of receptor by 750 X g pellet (not 
shown). From these experiments proteolytic activities 
do not seem to be responsible for the inactivation 
process of receptor by nuclei. 
We have then studied the effect of known phos- 
phatase inhibitors on receptor inactivation by 750 X g 
pellet, nuclei and nuclear extract from uterus. Fluo- 
ride, molybdate and zinc inhibit several phosphatases 
~clu~ng phosphoprote~ phosphatase [7-91. They 
almost completely inhibit the inactivation of 13H] - 
oestradiol-receptor complex by 750 X g pellet, or 
purified nuclei or nuclear extract (fig.1). These results 
strongly suggest that the inactivation of oestrogen 
binding activity by nuclei n the in vitro system is due 
to a dephosphorylation process, More work, however, 
is necessary to verify if the dephosphorylated mole- 
cule(s) is the receptor itself or molecules regulating 
the receptor activity. 
The possibility that steroid receptor can be inacti- 
vated by a dephosphorylation process has already 
been fo~ulated for the steroid-free form of gluco- 
corticoid receptor [ 10,l I]. Our resufts however for 
the first time suggest that nuclei are able to inactivate 
a steroid receptor by such a process. Since nuclei have 
a central role in the mechanism of action of steroids 
on the target issues, the inactivation process of the 
receptor by nuclei observed here could be tightly 
related to the mechanism of action of oestrogens. 
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